Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133709) titled 'Construction and Evaluaton of a Cllaborative Management Model for the Entre Prescription Circulaton Chain of hnovative Anticancer Medicines unde the Dual-Channel Policy' on Sept. 30.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Xiangya Hospital, Central South University
Condition:
B-cell lymphoproliferativediseases
Intervention:
usual care group:Routine services provided by hospitals and retail pharmacies
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: usual care group:88;Collaborative management group:88; ...